A Review of PCSK9 Inhibitors and their effects on cardiovascular disease
Cardiovascular disease remains the leading cause of morbidity and mortality in the world, with elevated low density lipoprotein-cholesterol (LDL-C) levels as a major risk factor. Lower levels of LDL-C can effectively reduce the risk of cardiovascular disease. Proprotein convertase subtilisin/kexin t...
Saved in:
Published in | Current topics in medicinal chemistry |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United Arab Emirates
08.08.2019
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!